A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer

Clinical trial NCT02138955 · COMPLETED

Trial details

NCT number: NCT02138955
Sponsor: SignPath Pharma, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patients w/Advanced Cancer That Failed Std of Care Therapy

Start date: 2014-03-01
Primary completion: 2017-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.